1 Feb/ 0 Comment/ 291 Hits/
Behestan Darou Firm/ Amgen Company were the organizer of the educational webinar in Mashhad University of Medical Sciences on the topic of new osteoporosis treatments on June 19 with 2 retraining points.
The purpose of the program was to introduce new drug therapies in osteoporosis (antiseptics) and the importance of assessing BMD and patients' management.
The keynote speakers were three prominent professors of rheumatology and neurosurgery. Also, a presentation on Prolia along with related articles and its effect on osteoporosis patients was presented by Dr. Borkhori, a product specialist of Amgen.
Behestan Darou Company was established in 2001 as a leading private company in the import, distribution and production of drugs and medical products and is currently one of the top pharmaceutical companies in terms of the value of products offered in the Iranian health market.
Select Category
medical
Pharmaceutical
Other
تمامی حقوق وبسایت متعلق به شرکت بهستان دارو می باشد. طراحی و اجرا توسط شرکت فراموج
